Tag: Alzheimer’s Disease Treatment
FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment
Washington, DC--Today, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease. Leqembi is the second of...